Tyra Biosciences (TYRA)
(Delayed Data from NSDQ)
$22.04 USD
+0.46 (2.13%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $22.05 +0.01 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
TYRA 22.04 +0.46(2.13%)
Will TYRA be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for TYRA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TYRA
Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet
Tyra Biosciences (TYRA) Upgraded to Buy: What Does It Mean for the Stock?
TYRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 27.27% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?
Here's What Could Help Tyra Biosciences, Inc. (TYRA) Maintain Its Recent Price Strength
Wall Street Analysts Think Tyra Biosciences, Inc. (TYRA) Could Surge 52.22%: Read This Before Placing a Bet
Other News for TYRA
Insider Sale: President and CEO Todd Harris Sells Shares of Tyra Biosciences Inc (TYRA)
Tyra Bioscience (TYRA) Receives a Buy from Piper Sandler
Tyra Biosciences management to meet virtually with Piper Sandler
Tyra Biosciences management to meet virtually with Piper Sandler
BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc